test

Our Publications

KPWHRI publicly shares its research findings in peer-reviewed journals.

View publications and posters for year: 

2022

Publications

Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in annual surveillance mammography participation among breast cancer survivors from 2004 to 2016. J Natl Compr Canc Netw. 2022;20(4):379-386.e9. doi: 10.6004/jnccn.2021.7081. PubMed

Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: a comparative modeling analysis. JAMA Oncol. 2022 Feb 17. doi: 10.1001/jamaoncol.2021.6204. [Epub ahead of print]. PubMed

Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, PaulChourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, B├Ącker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC; DMID 21-0012 Study Group. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 omicron variant. Cell Rep Med. 2022 Jul 19;3(7):100679. doi: 10.1016/j.xcrm.2022.100679. Epub 2022 Jun 20. PubMed

Mangione-Smith R, Robinson JD, Zhou C, Stout JW, Fiks AG, Shalowitz M, Gerber JS, Burges D, Hedrick B, Warren L, Grundmeier RW, Kronman MP, Shone LP, Steffes J, Wright M, Heritage J. Fidelity evaluation of the dialogue around respiratory illness treatment (DART) program communication training. LID - S0738-3991(22)00104-5 [pii] LID - 10.1016/j.pec.2022.03.011 [doi] Patient Educ Couns. 2022 Mar 14:S0738-3991(22)00104-5. doi: 10.1016/j.pec.2022.03.011 [Epub ahead of print] PubMed

Marcum ZA, Cohen JB, Larson EB, Williamson J, Bress AP. Can preferentially prescribing angiotensin II receptor blockers (ARBs) over angiotensinconverting enzyme inhibitors (ACEIs) decrease dementia risk and improve brain health equity? NAM Perspectives. May 2022; https://doi.org/10.31478/202205c.

pubmed-lt_small.png

PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950s. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.

Please see the PubMed disclaimer for information about copyright status of articles and abstracts accessed through PubMed.